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1. Introduction 
In recent years, the study of metabolomics and the use of metabolomics data to answer a 
variety of biological questions have been greatly increasing (Fan, Lane et al. 2004; Griffin 
2006; Khoo and Al-Rubeai 2007; Lindon, Holmes et al. 2007; Lawton, Berger et al. 2008). 
While various techniques are available for analyzing this type of data (Bryan, Brennan et al. 
2008; Scalbert, Brennan et al. 2009; Thielen, Heinen et al. 2009; Xia, Psychogios et al. 2009), 
the fundamental goal of the analysis is the same – to quickly and accurately identify 
detected molecules so that biological mechanisms and modes of action can be understood. 
Metabolomics analysis was long thought of as, and in many aspects still is, an 
instrumentation problem; the better and more accurate the instrumentation (LC/MS, 
GC/MS, NMR, CE, etc.) the better the resulting data which, in turn, facilitates data 
interpretation and, ultimately, the understanding of the biological relevance of the results.  
While the quality of instrumentation does play a very important role, the rate-limiting step 
is often the processing of the data. Thus, software and computational tools play an 
important and direct role in the ability to process, analyze, and interpret metabolomics data. 
This situation is much like the early days of automated DNA sequencing where it was the 
evolution of the software components from highly manual to fully automated processes that 
brought about significant advances and a new era in the technology (Hood, Hunkapiller et 
al. 1987; Hunkapiller, Kaiser et al. 1991; Fields 1996). Currently, software tools exist for the 
automated initial processing of metabolomic data, especially chromatographic separation 
coupled to mass spectrometry data (Wilson, Nicholson et al. 2005; Nordstrom, O'Maille et al. 
2006; Want, Nordstrom et al. 2007; Patterson, Li et al. 2008). Samples can be processed 
automatically; peak detection, integration and alignment, and various quality control (QC) 
steps on the data itself can be performed with little to no user interaction. However, the 
problem is that the generation of data, together with peak detection and integration, is the 
relatively simple part; without a properly engineered system for managing this part of the 
process the vast number of data files generated can quickly become overwhelming. 
Two major processes in metabolomic data processing are the verification of the accuracy of 
the peak integration and the verification of the accuracy of the automated identification of 
the metabolites that those peaks represent. These two processes, while vitally important to 
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the accuracy of the results, are very time consuming and are the most significant bottlenecks 
in processing metabolomic data. In fact, the peak integration verification step is often 
omitted due to the extremely large number of peaks whose integration must be verified. 
2. Background 
At the outset, running a metabolomics study is actually simple and straightforward. 
Samples are prepared for running on a signal detection platform, signal data is collected on 
samples from the instrumentation, the signals are translated into peaks, the peaks are 
compared to reference libraries for the identification of metabolites and those identified 
metabolites are then statistically analyzed with whatever metadata may exist for the 
samples. Alternatively, the entirety of the detected peaks resulting from the instrument 
signal data are statistically analyzed without metabolite identification prior to the statistical 
analysis.  
Once statistical analysis is completed and the significant signals have been stratified and 
metabolites identified, biochemical pathway analysis is performed to gain insight into the 
original biological questions the study asked. Too often, when the metabolomic experiments 
do not provide meaningful biological results, the realization may come that there’s so much 
variability in the data, it can’t be used to address the original objectives of the study. Despite 
the methods and software provided by the various instrument vendors, it turns out that 
running a global, non-targeted analysis of small molecules in a complex mixture that 
generates high-quality data and provides answers to biological questions is challenging. 
Doing so in a high-throughput environment is significantly more challenging. 
However, a high-throughput metabolomics platform that produces reliable, precise, 
reproducible, and interpretable data is possible. It simply requires the right process coupled 
with the right software tools. As with any high throughput process it is important to have a 
logical, consistent workflow that is simple, reproducible, and expandable without 
negatively impacting the efficiency of the process. It is important to know when human 
interaction is required and when it is not. Well designed and integrated software can 
efficiently handle the majority of the mundane workload, allowing human interaction to be 
focused only where required. 
3. Approach 
Metabolite identification is essential for chemical and biological interpretation of 
metabolomics experiments. Two approaches to metabolomic data analysis have been used 
and will be described in detail below. The main difference between the two approaches is 
when the metabolite is identified, either before or after statistical analysis of the data. 
To date, the most commonly used method of processing metabolomic data has been to 
statistically analyze all of the detected ion-features (‘ion-centric’). Ion features, defined here 
as a chromatographic peak with a given retention time and m/z value, are analyzed using a 
statistical package such as SAS or S-plus to determine which features vary statistically 
significantly and are related to a test hypothesis (Tolstikov and Fiehn 2002; Katajamaa and 
Oresic 2007; Werner, Heilier et al. 2008) . The significant ion feature changes are then used to 
prioritize metabolite identification. One issue with this type of approach is the convoluted 
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nature of the data being analyzed. In many cases the “statistically significant ion-features” 
are various forms of the same chemical and are therefore redundant information. Most 
biochemicals detected in a traditional LC- or GC-MS analysis produce several different ions, 
which contributes to the massive size and complexity of metabolomics data. In addition, 
there are an even larger number of measurements for each experimental sample which 
impacts the false discovery rate (Benjamini and Hochberg 1995; Storey and Tibshirani 2003).  
In the ‘chemo-centric’ approach to metabolomics data analysis discussed here, metabolites 
are identified on the front-end through the use of a reference library comprised of spectra of 
authentic chemical standards(Lawton, Berger et al. 2008; Evans, Dehaven et al. 2009). Then, 
instead of treating all detected peaks independently, as is done in the ion-centric approach, 
the chemo-centric method selects a single ion (‘quant-ion’) to represent that metabolite in all 
subsequent analyses. The other ions associated with the metabolite are essentially 
redundant information that only add to data complexity. Furthermore, the statistical 
analysis may be skewed since a single metabolite may be represented by multiple ion peaks, 
and the false discovery rate increased due to the large number of measurements relative to 
the number of samples in the experiment. Accordingly, by taking a chemo-centric approach 
any extraneous peaks can be identified and removed from the analysis based on the 
authentic standard library/database. Since the number of features analyzed statistically 
contributes to the probability of obtaining false positives, analyzing one representative ion 
for each metabolite reduces the number of false positives. Further, the chemo-centric data 
analysis method is powerful because a significant amount of computational processing time 
and power can be saved simply due to data reduction.  
The majority of work and complexity with the chemo-centric approach are: first, the 
generation of the reference library of spectra from authentic chemical standards; second, the 
actual identification of the detected metabolites using the reference library; and third, the 
ability for quality control (QC) of the automated metabolite identification, peak detection 
and integration. Notably, the QC of the automated processes is often overlooked. However, 
the QC step is critical to ensure that false identifications and poor or inconsistent peak 
integrations do not make their way into the statistical analysis of the experimental results. 
The generation of a reference library entry made up of the spectral signature and 
chromatographic elution time of an authentic chemical standard is relatively 
straightforward, as is the generation of spectral-matching algorithms that use the reference 
library to identify the experimentally detected metabolites. In contrast, performing the QC 
step on the automated processes, including peak detection, integration and metabolite 
identification, is time and human resource intensive.  
Not to be overlooked, an issue with using a reference library comprised of authentic 
standards is dealing with metabolites in the samples that are not contained within the 
reference library. The power of the technology would be significantly reduced if it was 
limited to identifying only compounds contained in the reference library. Through 
intelligent software algorithms, it is possible to analyze data of similar characteristics across 
multiple samples in a study to find those metabolites that are unknown by virtue of not 
matching a reference standard in the library, and, in the process, group all the ion-features 
related to that unknown together by examining ion correlations across the sample set 
(Dehaven, Evans et al. 2010). One such method capitalizes on the natural biological 
variability inherent in the experimental samples, using this variation the metabolites and 
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their respective ion-features can reveal themselves and be entered into the chemical 
reference library as a novel chemical entity (Dehaven, Evans et al. 2010). The unknown 
chemical can then be tracked in future metabolomics studies, and, if important, can be 
identified using standard analytical chemistry techniques. 
Without going into detail, it is important to note that the sample preparation process is 
critical. High quality samples that have been properly and consistently prepared for analysis 
on sensitive scientific instrumentation are of extreme importance. Ensuring this high quality 
starts with the collection and preparation of the samples. No software system is going to be 
able to produce high-quality data unless ample effort is focused on consistently following 
standardized protocols for preparing high quality samples for analysis. 
The following discussion, examples and workflow solutions make use of GCMS or LCMS 
(or both) platforms for metabolomic analysis of samples, although the concepts in general 
could apply to a variety of data collection techniques. Software tools are also presented to 
demonstrate the application of the concepts that are discussed but the tools themselves will 
not be discussed in great detail. It is also important to note that achieving the greatest 
operation efficiency of the process relies on treating all of the experimental samples in a 
study as a set and not as individual files. By using tools to analyze and perform quality 
control on the samples as a single group or set it becomes much easier to spot patterns that 
can be useful to determine what is going on in the overall process. 
4. Processing data files, peak detection, alignment, and metabolite 
identification 
4.1 File processing can become a major hurdle 
There is no shortage of software available on the market to read spectral data and detect the 
start and the stop of peaks, and the baseline, and then calculate the area inside of those 
peaks. Each instrument vendor provides some flavor of detection and analysis software 
with their instrument and several open-source and commercial efforts to read spectral data 
and produce integrated peak data regardless of vendor format are available (Tolstikov and 
Fiehn 2002; Katajamaa and Oresic 2005; Katajamaa and Oresic 2007). In almost all cases, 
these packages do a complete job of finding and integrating peaks and do so in a reasonable 
amount of time. Thus, the peak detection and integration process is not the rate-limiting step 
when it comes to data quality and automated processing.  
As it turns out, the file processing problem is primarily a file management problem that is 
the result of two issues – human and machine. The first problem stems from human 
interaction, in that a human being can introduce more error and inconsistency than is 
acceptable. Optimally, a human should play no role in the naming or processing of 
instruments data files. Naming of instrument data files should take place within the system 
used to track sample information, a LIMS for instance. The LIMS or other sample tracking 
system should generate a sample list and run order for the samples to be run on the 
instrument using a consistent naming convention that can be easily associated with the 
sample in question. The second problem stems from both machine and human. The software 
performing the peak detection and integration must have the capability of automatically 
processing a data file when presented with it, then archiving the file when completed. And, 
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in high-throughput mode, it is best not to have humans manage data files, either in storage 
locations, or, as noted above, in naming. For consistency, it is imperative that the machines 
control this step; running one experiment on one machine may be manageable manually but 
running experiments in tandem or on more than one instrument can easily result in 
misnaming, file version problems, location mishaps, etc. if file management is not 
automated. 
4.2 Manual integration of peak data is inadequate for high-throughput processing 
Processing metabolomics data in a high-throughput setting requires automated processing 
of data files. While an SDK (software development kit) is provided by many instrument 
vendors, and there are commercial and open source packages for creating this functionality 
available (Smith, Want et al. 2006), not all vendor software permits this functionality. One of 
the main reasons automated peak integration works well is because it allows data to be 
rapidly uploaded and processed. Manual integration, while perhaps more accurate, 
dramatically slows the peak analysis process. Further QC and refinement of the automated 
peak integration can be performed more optimally later in the process, where, in practice, 
the bar for peak detection can be slightly lower. The reasons that the bar for peak detection 
can be reduced will be discussed below. 
4.3 Alignment based on peak similarity inadequate, retention index should be used 
Many of the software packages provide capabilities to align the chromatograms to 
account for time drift in an instrument. In many instances internal standards and/or 
endogenous metabolites are used across the analyzed samples to align chromatography 
based on their retention times, such that there is confidence that the same peak at the 
same mass is consistent among the data files. This approach should be avoided because 
while it works fine for peak analysis and chromatographic alignment on a single, small 
study it will only be applicable within that one study where retention times are quite 
consistent. This type of alignment approach makes it much harder to do a comparison to a 
reference standard library where a retention profile is used as matching criteria. The 
better choice is to opt for retention index (RI) calculation, which can correctly align 
chromatograms even over long periods of time where conditions can be vastly different 
dependent on the condition in these systems. Using a retention index method, each RT 
marker is given a fixed RI value (Evans, Dehaven et al. 2009). The retention times for the 
retention markers can be set in the integrator method and the time at which those internal 
standards elute are used to calculate an adjustment RI ladder. All other detected peaks 
can then use their actual retention time and adjustment index to calculate a retention 
index. In this way, all detected peaks are aligned based on their elution relative to their 
flanking RT markers. An RI removes any systematic changes in retention time by 
assuming that the compound will always elute in the same relative position to those 
flanking markers. Because of this, a unique time location and window for a spectral 
library entry can be set in terms of RI, thereby ensuring that metabolites don’t fall outside 
the allowed window over a much longer period of time. Retention indices have 
predominately been used for GC/MS methods however this approach can also have great 
success for LC/MS data alignment as well. LC/MS is certainly more complex as certain 
metabolites and classes of metabolites show more chromatographic shift in their RI 
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markers than others, in these cases increasing the expected RI window of the library entry 
in conjunction with mass and fragmentation spectrum data is sufficient for accurate 
identification. The advantages over many of the widely available chromatographic 
alignment tools, eg. XCMS (Smith, Want et al. 2006), as it can be used to match against a 
RI locked library over long periods of time and can align data from different biological 
matrices without potential distortion from structural isomers. 
4.4 Identifying metabolites 
Metabolite identification is essential to the biochemical and biological interpretation of the 
results of metabolomic studies. Lists of integrated peak data are of little use unless a library 
of spectra is available to compare peak data with to identify the metabolites represented by 
those peaks. Publicly created and maintained databases do exist (Wishart, Tzur et al. 2007; 
Wishart 2011). However, the utility of these databases to identify metabolites of interest 
from metabolomics studies is currently limited for a number of reasons. First, due to the 
significant number of different instrument types, methods, and runtimes it is a nearly 
impossible task to account for every possible representative of the spectra and retention time 
for a given metabolite under all of these diverse conditions. Second, metabolomics 
experiments utilize a global non-targeted approach where the method is optimized to 
measure as many metabolites as possible in a wide range of biological sample types (i.e., 
matrices). Certain metabolites behave differently in one matrix than in another, or 
differently in the same matrix under different conditions, for example in response to an 
experimental treatment versus when non-treated. Third, there may be areas of the 
chromatogram with a high-degree of co-eluting metabolites. Public databases of metabolite 
spectra can provide useful information in many cases, especially when no existing library 
exists. However, the public information is limited and certainly not as informative or 
reproducible as generating an in-house chemical reference library using the same equipment 
and protocols as used to analyze the experimental samples.  
While requiring a significant resource commitment, the generation of an internal library of 
authentic chemical standards is a worthwhile task with significant advantages for high-
throughput metabolomics. An in-house library of authentic standards provides a clear 
representation of the spectra resulting from a metabolite on the same instrument and 
method used to analyze the experimental sample. A retention index for the internal library 
can be calculated and set, resulting in library entries that are fixed in time. Consequently 
consistent, reliable, standard spectra that do not change over time are ensured which, in 
turn, facilitates automated, high confidence metabolite identification. 
Software for performing spectral library matching, much like peak integration software 
discussed above, is readily accessible (Scheltema, Decuypere et al. 2009). From open-source 
applications to commercial packages there are numerous choices. Many software packages 
use some type of forward or reverse (or both) fitting algorithm that use mass and time 
components to match peaks to metabolites of similar mass and peak shape within a time 
window. Due to their global, non-targeted nature, metabolomic studies are not optimized 
for any metabolite in particular, so a positive metabolite identification in a metabolomics 
analysis is almost never a binary decision. It is highly unlikely to simply have a positive yes 
or no for a metabolite identification, instead it is more likely to have a probability score 
associated with the identification. Quality control of the scoring is essential and one of the 
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most important aspects of metabolomics analysis, especially for running studies in high 
throughput. 
4.5 Unnamed metabolites 
A chemo-centric approach, based on a reference library, to high-throughput metabolomics is 
a powerful method to identify metabolites within biological samples. If there is any 
weakness to using in-house generated reference libraries it would be in the realm of 
identifying the redundant ion peaks that originate from metabolites that do not exist in the 
library. Methods available to identify and group these redundant ion peaks are limited 
(Bowen and Northen; Dunn, Bailey et al. 2005; Wishart 2009). 
The most common approach is to rely on the chromatographic elution similarity between 
these redundant ions as well as looking for user defined mass relationships between the 
ions that are consistent with known chemical modifications. The effectiveness of this 
approach is limited in highly complex samples where metabolite co-elution is common. In 
such situations, there can be multiple metabolites eluting simultaneously which 
confounds identifying their respective ions based on elution. Another shortcoming of this 
method is the inability to identify unique modifications or fragments that are not known 
to occur.  
A method that has yielded very good results for analyzing spectrometry data and fits well 
within the framework of high-throughput metabolomics is the QUICS method (Dehaven, 
Evans et al. 2010) This method to identify and quantify individual components in a sample, 
(QUICS), enables the generation of chemical library entries from known chemical standards 
and, importantly, from unknown metabolites present in experimental samples but without a 
corresponding library entry. The fundamental concept of this method is that by looking at 
detected ion features across an entire set of related samples, it is possible to detect subtle 
spectral trends that are indicative of the presence of one or more obscure metabolites. In 
other words, because of the natural biological variability of the metabolite in the study 
samples, by performing an ion-correlation analysis across all samples within a given dataset 
it is possible to detect ion features that are both reproducible and related to one another. 
Using the cross sample correlation analysis it is then possible to add the spectral features for 
that metabolite to the reference library. Then the metabolite can be detected in the future 
using that library entry, even though the metabolite is unknown, i.e., without an exact 
chemical identification. Importantly, this method captures any unknown metabolite because 
it does not require chemical adducts and/or fragment products to be previously known or 
expected. Another advantage is that statistical analysis can be used to determine whether or 
not the metabolite is significant or of interest. In this way the important unnamed 
metabolites can be focused on for the work of performing an actual identification which 
enhances efficiency and reduces the work to identifying the most important metabolites. 
5. Quality control 
The ability to perform thorough quality control on identified metabolites in metabolomics 
studies is extremely important. The higher the quality of data entering statistical analysis, 
the higher the probability that the study will provide answers to the questions being asked. 
This section will focus on three aspects of quality control – quality control samples (i.e., 
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blanks, technical replicates), software for assessing the quality of metabolite identification, 
and software for assessing the original peak detection and integration. This last point may 
seem out of order but for reasons to be described results in an invaluable check of the peak 
quality. 
5.1 Blanks – Identify the artifacts of the process 
A commonly overlooked issue in biological data collection is the presence of process 
artifacts. A process artifact is defined as any chemical whose presence can be attributed to 
sample handling and processing and not originating from the biological sample. In all 
analytical methods chemicals are inadvertently added to samples. Artifacts can include 
releasing agents and softeners present in plastic sample vials and tubing, solvent 
contaminants, etc. One of the easiest and most efficient means of identifying artifacts is to 
run a “water blank” sample interspersed throughout the entire process alongside the true 
experimental samples. In this way, the water blank will acquire all the same process-
related chemicals as the experimental samples. Consequently, identification and in silico 
removal of artifacts can be accomplished by identifying those chemicals detected at 
significant levels in the water blank when compared to the signal intensity in the 
experimental samples. If not identified and removed, process artifacts can inadvertently 
arise as false discoveries.  
5.2 Technical replicates – Find the total process variation 
The intrinsic reproducibility of a method is critical since it has considerable impact on 
the significance and interpretation of the results. For example, if a 20% change was 
detected between treatment and control samples but the analytical method had a 20% 
coefficient of variation (CV) for that measurement, concerns regarding the accuracy of 
the measurement would call into question the biological relevance of that change in 
measurement. On the other hand, if the analytical method had a 2% CV for that same 
measurement it is much more likely that the same 20% change is of “real” biological 
significance. Clearly, smaller analytical variability of the method enables small, yet 
meaningful, biological changes to be detected accurately and consistently. It is therefore 
critical to determine the analytical reproducibility/variability of a method for every 
compound/measurement.  
By far the most common way to assess system stability and reproducibility is by use of 
internal standards. Internal standards can be measured throughout a study to monitor 
system reproducibility and stability. The drawbacks to this approach are that the number of 
standards is typically small and do not represent the myriad of chemical classes typically 
observed in a metabolomics analysis.  
Another common approach to address method variability is by the use of technical 
replicates. With this approach the same biological sample is run multiple times, e.g., in 
triplicate, to determine method reproducibility. The advantage of this method over internal 
standards is the ability to determine the CV of the method for each compound detected 
within the matrix of the samples being analyzed. However, the disadvantage is that, while 
the replicate approach is extremely effective, it is also very time-consuming and of limited 
practicality in a high-throughput setting.  
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An extremely practical and efficient approach is to run a technical replicate of a sample 
composed of a small aliquot from all the samples in a study interspersed among individual 
experimental samples. An aliquot of each experimental sample is pooled, then an aliquot of 
the pooled sample mixture is run at regular intervals—every n number of experimental 
sample injections (n to be set by operator). An advantage of this pooled sample is that it 
provides CV information for all compounds detected in the study, in the matrix under 
study. Another advantage is that far less instrument analysis time is required which makes 
it far more practical in a high-throughput laboratory.  
5.3 Quality control of automated metabolite identifications 
Performing quality control (QC) for a given metabolite identification can be an exhaustive 
and time-consuming task. The work to perform QC on every metabolite identification in 
every sample within a metabolomics study can seem to be a nearly-impossible task. 
Considering a relatively small metabolomics study of 50 samples, with an average of 800 
identified metabolites per sample, there would be 40,000 spectra to review for just that one 
study. Yet, as time-consuming as this process is, quality control of automated library calls is 
vital for ensuring accuracy and high confidence in the data which, in turn, enables 
meaningful biological interpretation of the results. A software package that can permit this 
process to proceed quickly and efficiently is critical in a high-throughput setting.  
Visual inspection of all the samples in a study simultaneously enables rapid metabolite 
identification QC. By representing the sample data within a study as a single set in a visual 
manner and creating tools that quickly allow an analyst to investigate and manually accept 
or reject an automated metabolite identification, the task of performing quality control on 
even extremely large datasets can be accomplished rapidly and easily. An example of a 
visual data display is shown in Figure 1. In this example the panel across the top (Figure 1A) 
contains a list of all of the metabolites identified by the software in the experimental samples 
being analyzed. By highlighting one chemical, the structure for that compound is displayed 
in an adjacent window (Figure 1B). The default visualization for viewing a highlighted 
metabolite is broken down into a distinct method chart for each analytical platform method 
that was used to identify that metabolite. The display also shows the multiple analytical 
platforms where the metabolite was identified. In this example, the same metabolite 
identified on a GC/MS platform (Figure 1C), and LC/MS negative ion platform (Figure 1D) 
is shown. Within each chart, the individual sample injections, each with a unique identifier, 
make up the y-axis (Figure 1E). The x-axis represents the retention index (RI) time scale. 
Navigation of the interface involves scrolling down through the data table window (Figure 
1A). From the interface it is also possible to review annotation regarding the highlighted 
metabolite (Figure 1F), view the analytical characteristics (e.g., Mass, RI) of the metabolite as 
well as toggle through RI windows containing ions characteristic of that metabolite (Figure 
1G). 
An example plot of data from the LC/MS negative platform is illustrated in Figure 2. In this 
example the samples are initially sorted by the sample type, namely process blank, technical 
replicate, or experimental sample. The dots within each method chart represent the detected 
ion peaks, and each point has associated peak area, mass to charge (m/z), chromatographic 
start and stop data which can be accessed by clicking on the individual dots, as shown in 
Figure 3.  
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Fig. 1. Graphical user interface showing the view for the proposed identification of 
heptadecanoic acid. (A) Distinct list of identified metabolites for the loaded sample set. This 
list includes any metabolite identified at least once in any sample with the set. It also 
includes summary statistics such as averages for spectral scoring and chromatographic peak 
intensities, number of times detected, and status.(B) Chemical structure for displayed 
metabolite. (C) Data for the posed library identification heptadecanoic acid from the GC/MS 
method. (D) Data for the posed library identification heptadecanoic acid from the LC/MS 
negative ion method. (E) List of unique sample identifiers comprising the study. (F) 
Comment field for storing and displaying annotations that are relevant to the currently 
displayed metabolite. (G) List of other ion peaks that exist as part of the spectral library 
entry. (H) List of sample sorting options including associated sample metadata; diagnosis, 
group and subgroup.  
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Fig. 2. Plot for LC/MS negative method. Individual samples in the sample set are displayed 
and sorted on the y-axis. Chromatographic retention time is presented on the x-axis. 
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Fig. 3. Raw MS data can be accessed for each sample via graphical user interface links. Each 
“dot” represents the detected and integrated ion peak in the individual sample listed on the y-
axis. Thus, each “dot” has an associated area, height intensity, chromatographic start, stop and 
apex retention time/retention index. Color and shape of “dot” are indicative of the quality of 
the match to the posed library identification (see chart 1) and can be used to launch underlying 
data such as raw MS data (insert). Colors of the samples listed on the y-axis  also hold meaning 
(see chart 1). 
www.intechopen.com
 Software Techniques for Enabling High-Throughput Analysis of Metabolomic Datasets 
 
179 
This type of visualization permits the analyst to quickly verify the quality (i.e., QC) of the 
automated peak detection and integration software. Each dot that is representative of an ion 
peak can be individually removed/rejected from the proposed library identification. In this 
way, extraneously detected ion peaks in the window can be visualized and individually 
removed, as is the case shown in Figure 4. In this particular example there are two closely 
eluting ion peaks with the same mass. One of the peaks is 2-stearoylglycerophosphocholine 
(Figure 4, panel A) and the other is 1-stearoylglycerophosphocholine (Figure 4, panel B). In 
both panels the correct peak must be manually approved and the incorrect peak rejected 
(indicated by red dots). Stray detected ions can also be individually rejected from the 
identifications. In addition, the interface permits the interrogation of the integration quality 
of individual ion peaks since each dot is linked to the raw ion data as illustrated in Figure 4, 
panel C and Figure 5, panel B. In this fashion any potential inaccuracy in the automated 
detection and integration of individual peaks can be readily determined.  
In addition to being able to curate each sample individually, the automated library 
identification for an entire sample set can be rejected. An example of this is shown in Figure 
5. The presence of multiple dots for each sample in the RI window (Figure 5 A) coupled 
with the ability to view the underlying ion data (Figure 5B) makes it apparent that the 
automated metabolite identification was based on erroneous ion peaks that resulted from 
the integration of noise. As a result the automated call for the entire sample set was 
manually rejected by the analyst. Accordingly, with this visualization tool the analyst can 
rapidly determine the quality of the automated detection and integration and remove from 
the dataset any peaks which are of questionable quality.  
In addition to being able to QC the automated peak detection and integration software, an 
interface such as this allows an analyst to visually inspect the quality of the library 
identification in each individual sample. In the graphical plot the “dot” representing the 
detected ion peak for the proposed metabolite identification is displayed in various color 
and shape combinations. Each combination of color and shape within each plot is an 
indicator of the quality of the automated metabolite identification, which greatly aids the 
analyst in making the quality assessment rapidly. Listed in Table 1 are possible color and 
shape combinations with the meaning for each. The quality assessment is based on spectral 
library matching logic (Evans, Dehaven et al. 2009). This graphical display allows the 
analyst to look at a proposed identification for a given metabolite made by the software and 
immediately determine its quality and confidence based on spectral match scores. In this 
way, the automated metabolite identifications for large datasets can be quickly evaluated by 
the analyst. An example of a proposed call for a group of ions in a sample set where the 
MS/MS spectral match was poor is shown in Figure 6. The low data quality is readily 
apparent by the preponderance of the red colored dots in the plot. 
5.4 Quality control of automated integration 
GC/MS and LC/MS/MS measurements of a bio-sample usually produce millions of ions, 
which are fragments and/or adducts/aggregates of the metabolites, artifacts from the 
system, and potentially false ions from background noise. Ideally, the false ions from the 
background noise are removed, using, for example, a Gaussian smoothing algorithm to filter 
them out of the dataset. The remaining ions are then integrated across time within a mass 
window to identify ion chromatographic peaks. Thousands of such ion chromatographic 
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Fig. 4. Example of the visualization of closely related ion peaks. (A) Two possible ion peaks 
were detected in same retention window for 2-stearoylglycerophosphocholine. In this case 
the ion peak to the left is the correct peak (green and blue dots with arrow) and the peak on 
the right was rejected (red). (B) The peak on the right is actually 1-
stearoylglycerophosphocholine. Therefore, the peak on the right is correct (green and blue 
with arrow) while the peak on the left is rejected (red). In addition ion peaks in dashed 
boxes are stray detected ion peaks not associated with the peak for 1-
stearoylglycerophosphocholine ion peaks that were rejected (red). (C) The extracted ion 
chromatogram for one of the samples in the sample set for this ion shows the two peaks are 
well separated and accurately integrated. 
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Fig. 5. Example of rejected identification for entire sample set. (A) Detected ion-peaks that 
result from (B) a noisy baseline as seen in one injection; the entire library identification for 
this LC/MS positive method is rejected. 
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Feature Color Meaning 
Blue  
Identified metabolite with high confidence 
in the quality of the identification. These 
points represent the highest level of 
confidence for a metabolite identification. 
Green 
Identified metabolite with some confidence 
in the quality of the identification. These 
points require further research depending 
on the context. 
Red  
Identified metabolite with very low 
confidence in the quality of the 
identification.  
Orange  
Orange points represent a peak that was 
within and near the time window but was 
not called as the metabolite. There may be 
cases such as for very low-level peaks that 
the scoring was not adequate to make a call 
but taken in context with the rest of the 
dataset, the peak is indeed the metabolite in 
question.  
Feature Shape Meaning 
Circle Regular peak. 
Triangle 
For LC/MS a triangle represent that there 
exists underlying MS/MS data to confirm a 
peak’s identity. 
Other shape 
Shapes other than a circle or triangle 
represent that a user has opted to also 
observe ion features that exist as part of the 
library entry other than the ion feature used 
for quantification. 
Sample Label Color (y-axis label) Meaning 
Black 
Black labels mean that there is one and only 
one ion feature representing the metabolite 
identification in the given time window. 
Blue 
Blue labels indicate that there is more than 
one ion-feature within the time window 
that may represent the metabolite 
identification. 
Red 
Red labels are shown when there are no 
possible hits for the given metabolite. 
Table 1. Color/Shape combinations to demonstrate peak quality 
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Fig. 6. An example of an entire metabolite call that was rejected because the MS/MS spectral 
match was poor. (A) Red color of dots indicates that the MS/MS spectral match was of low 
quality. (B) Experimental MS/MS spectrum from one injection compared to the reference 
library spectrum for beta-alanyl-L-histidine (carnosine). 
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peaks per sample are typically detected and integrated. Those peaks are organized into 
groups within a time window, adjusted/aligned by retention index from known internal 
standards to account for time drift and matched to library compounds (metabolites). For 
LC/MS/MS, secondary fragment ions of the primary quantification ion can also be used to 
match library compounds.  
Obviously, all the profiling and analysis of metabolites in biological samples are dependent 
on the accuracy and consistency of ion chromatographic peak detection and peak 
integration. However, GC/MS and LC/MS/MS measurements are complicated by a 
number of factors; for example, the co-elution of metabolites because of incomplete 
separation, the existence of artifacts from the system, the background noise, and the 
potential wide concentration ranges of metabolites in the sample. Such complexities can 
affect the detection and determination of the peak start, the peak end and the peak baseline. 
Incomplete separation can lead to shoulders on peaks on either the leading edge or the 
trailing edge of the main peak from metabolites present at higher concentrations. When 
compared to the baseline, the peak start and the peak end would be characterized by a 
baseline peak or a drop peak. Because of the complexity and variance inherent in biological 
samples, the same metabolite in different samples may have been automatically detected 
differently in regard to peak start, peak end and peak background. For example, in some 
cases, the ion chromatographic peaks for metabolites present in only trace amounts may not 
be well shaped, especially when a noisy background is present, so integration of such peaks 
might be quite variable from sample to sample. In other cases, the major ions for a 
metabolite may appear as a small shoulder on a larger ion peak and, as a result, may not 
even be detected during the automatic peak detection/integration process from sample to 
sample. In still other instances, a metabolite present in high concentrations may overload the 
column and distort the chromatographic profile, leading to peak splitting. For such high 
concentration metabolites the automatic library match may pick only one of the two peaks 
for quantification which will give an erroneously low value for the amount of the metabolite 
in the sample. Clearly, each of the above examples will lead to peak detection and 
integration inconsistency and inaccuracy across the samples in a sample set, which will 
potentially lead to wrong conclusions and wrong decisions in later analysis.  
Global metabolomics has other challenges when it comes to peak detection. Unlike targeted 
metabolomics, global metabolomic profiling cannot be optimized for each metabolite that is 
present within a biological sample. Chromatography methods must be broad enough to 
detect as many of the metabolites in the sample as possible, regardless of chemical 
characteristics. Consequently, chiral compounds cannot be resolved and structural isomers 
are usually not well resolved in global metabolomics profiling. In downstream analysis for 
identified metabolites, structural isomers might better be combined to represent the 
metabolites, or, if one isomer is more crucial in elucidating the metabolism or biochemical 
pathway, consistently picking that one form across samples would ensure analytical 
consistency.  
A software solution to detect and correct such inconsistencies in ion peak integration and 
library matching across samples in a sample set could be developed. After the quality control 
phase of the identification of the detected metabolites is completed, a deeper examination of 
the consistency of peak detection and integration could be performed to ensure consistency 
and accuracy. The quality control phase of automatically detected metabolites involves 
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providing a high-quality, filtered list of identified metabolites devoid of noise and artifactual 
metabolites to the end user (Figure 7). Sample set sizes range from a few samples to hundreds 
and even thousands of samples. Because hundreds of metabolites can be detected and 
measured in each sample, this type of quality control operates on the ‘quant’ ion peaks –those 
peaks detected in the samples that are used for quantification of those metabolites. 
 
Fig. 7. Graphical View of Peak Integration for an Identified Metabolite: Identified 
metabolites (200~600) in the specified sample set (Upper Left); Quantitation peaks for 
selected metabolite in the samples in the sample set (Middle Left); Type of samples and 
Information about the sample peaks (Lower Left); Peak chromatograms (Upper Right); 
Sample peak area (blue for original integration and red for re-integrated (Lower Right). 
The chromatograms of the ion peaks representing the quantitative mass from all of the 
samples in a set must be evaluated to determine if:  
 the majority of the sample peaks are on the trailing edge of another peak,  
 the majority of the sample peaks are on the leading edge of another peak,  
 the majority are peaks that encompass two peaks in other samples, as a result of peak 
splitting. 
Peak integration ranges are evaluated with alignment by retention index and the statistics of 
peak limits across the sample set. Accordingly, in addition to user specified manual 
correction, corrections in consistency and re-integration would be suggested and presented 
to the analyst for review and approval. Functionally, this type of software would give the 
end user a variety of methods to both investigate the automated integration and peak calls 
and to correct them as necessary. The software features must include: 
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 Automatic merging of approved peaks from the sample that match to the same library 
compound. 
 Detection of shoulder peaks based on RI-aligned peak start or peak end distribution 
across the samples. 
 Manual integration 
 Manual peak splitting 
 Show peak chromatograms in overlay mode or tabular mode for easy review/manual 
re-integration. 
 Update peak integrations, peak recovery and library rematch  
When an identified metabolite in a biological sample is at a sufficiently high concentration, 
it can overload the column and distort the chromatographic peak. Even though it may be 
out of the linear range, a consistent integration of the peak is still needed to characterize the 
group of samples. Distorted peaks tend to drive the integration software to identify a less 
than optimal peak to be used for quantification. In Figure 7, the peak for glucose was 
incorrectly split in a handful of samples by the automated peak integrator. By examining the 
consistency of the peak integration across the set of samples it is possible to easily identify 
and correct this situation. As shown in the example in Figure 8, this correction would 
improve the relative standard deviation from 20.1 to 7.4 
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Fig. 8. Combining Peaks 
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As illustrated in Figures 9 and 10, small peaks on the leading or trailing side of a larger peak 
are often integrated inconsistently: 
 Small shoulder peaks are detected 
 Small shoulder peaks are not detected  
 Small shoulder peaks are combined into the main peak 
In Figure 8, the major peak on the left is identified as cysteine, whereas the shoulder on 
the right side is from threonate. In one sample, the small peak from threonate was 
inaccurately combined into the main peak for cysteine when it was automatically 
integrated, thus inadvertently increasing the response for cysteine in that sample. After 
re-integration the erroneous integration was corrected thereby restoring the correct 
integration for cysteine and permitting the independent detection of threonate in the 
sample as well.  
 
 
Fig. 9. Examples in inconsistent shoulder peaks. Splitting of shoulder (Upper panel); Area 
change after re-integration (Blue for automatic integration and red for re-evaluated 
integration (Lower panel). 
In Figure 10, the major peak on the right is identified as 1-docosahexaenoylglycero-
phosphocholine (1-DHGPC), whereas the shoulder on the left side is identified as 2-
docosahexaenoylglycerophosphocholine (2-DHGPC). In one sample, the peak for 2-DHGPC 
was inaccurately combined into the peak for 1-DHGPC when it was automatically 
integrated. In another sample, the baseline was not calculated consistently. The curves at the 
lower right show the correction. After re-integration the erroneous integration was corrected 
and the small peak for 2-DHGPC was recovered.  
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Software that can detect inconsistencies in peak detection and integration across samples in 
a sample set can ultimately improve the accuracy in the integration of peaks that have been 
identified as metabolites; this in turn leads to lower CV’s and more accurate statistical 
analysis which can contribute significantly to the elucidation of metabolism and metabolite 
pathway. 
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Fig. 10. Examples of inconsistent shoulder peaks 
6. Conclusion 
Metabolomics as a technology has demonstrated clear utility in a broad array of biological 
applications. The applications are not only in demonstrating simple metabolic comparisons 
between treated and control groups but in studies involving biomarker discovery, drug 
development/MOA/recovery, bio-processing, agricultural applications, consumer products, 
diagnostics, and so on (Sreekumar, Poisson et al. 2009; Berger, Kramer et al. 2007; Barnes, Teles 
et al. 2009; Boudonck, Mitchell et al. 2009; Ma, Ellet et al. 2009; Ohta, Masutomi et al. 2009; 
Watson, Roulston et al. 2009; Oliver, Guo et al.). The ability to run metabolomic studies in high-
throughput has been a challenge thus far, not so much because of the complexity or size of the 
data, but because of the difficulty in generating reproducible data having low process variation 
that can be quantified, is devoid of artifactual components, and provides high confidence in the 
identification of metabolites. Without knowledge of the variability of the process on a 
metabolite by metabolite basis, it is not possible to determine the true biological variability and 
thus, cannot provide accurate answers to the questions that under investigation.  
As demonstrated here, quality and the throughput of processing sample data for 
metabolomics studies do not need to be mutually exclusive. By taking an intelligent 
engineering approach to the data workflow, knowing when to automate a process and 
developing software solutions that are streamlined for this process, the processing of sample 
data for metabolomics studies can be done in significantly high volume and with high quality. 
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